BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 7630147)

  • 1. Activated Inositol Phosphate, Substrate for Synthesis of Prostaglandylinositol Cyclic Phosphate (Cyclic PIP)-The Key for the Effectiveness of Inositol-Feeding.
    Gypakis A; Adelt S; Lemoine H; Vogel G; Wasner HK
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers.
    Schantl AE; Verhulst A; Neven E; Behets GJ; D'Haese PC; Maillard M; Mordasini D; Phan O; Burnier M; Spaggiari D; Decosterd LA; MacAskill MG; Alcaide-Corral CJ; Tavares AAS; Newby DE; Beindl VC; Maj R; Labarre A; Hegde C; Castagner B; Ivarsson ME; Leroux JC
    Nat Commun; 2020 Feb; 11(1):721. PubMed ID: 32024848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition.
    Tortolini C; Gigli V; Rizzo F; Lenzi A; Bizzarri M; Angeloni A; Antiochia R
    Sensors (Basel); 2023 Nov; 23(22):. PubMed ID: 38005597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).
    Thomas MP; Mills SJ; Potter BV
    Angew Chem Int Ed Engl; 2016 Jan; 55(5):1614-50. PubMed ID: 26694856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate.
    Russell ST; Siren PM; Siren MJ; Tisdale MJ
    Br J Cancer; 2010 Mar; 102(5):833-6. PubMed ID: 20145616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists.
    Edvinsson L; Erlinge D; Sun XY; Hedner T
    Pharmacol Toxicol; 1994; 74(4-5):193-201. PubMed ID: 8090686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature.
    Sun X; You J; Hedner T; Erlinge D; Fellström B; Yoo H; Wahlestedt C; Edvinsson L
    J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
    Sun XY; Dahlöf C; Edvinsson L; Hedner T
    Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP).
    Wahlestedt C; Reis DJ; Yoo H; Adamsson M; Andersson D; Edvinsson L
    Neurosci Lett; 1992 Aug; 143(1-2):123-6. PubMed ID: 1436655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
    Sun XY; Edvinsson L; Hedner T
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission.
    Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T
    J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?
    Bell D; McDermott BJ
    Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.